Novo Nordisk issued FDA warning letter over adverse event reporting
Go back to Novo Nordisk issued FDA warning letter over adverse event reporting| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.28 -0.05 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.33 | 52 Week High | $59.00 | |||
| Open | $45.80 | 52 Week Low | $32.80 | |||
| Day High | $46.16 | P/E | N/A | |||
| Day Low | $45.22 | EPS | $0.00 | |||
| Volume | 4,392,377 | |||||
